Teladoc Health
TDOC
728 hedge funds and large institutions have $13B invested in Teladoc Health in 2021 Q4 according to their latest regulatory filings, with 124 funds opening new positions, 233 increasing their positions, 256 reducing their positions, and 142 closing their positions.
4.12% more ownership
Funds ownership: 83.93% → 88.05% (+4.1%)
9% less repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 256
4% less funds holding
Funds holding: 760 → 728 (-32)
13% less first-time investments, than exits
New positions opened: 124 | Existing positions closed: 142
24% less capital invested
Capital invested by funds: $16.9B → $13B (-$4B)
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
35% less call options, than puts
Call options by funds: $1.39B | Put options by funds: $2.14B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$294M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$248M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$161M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$160M |
| 5 |
Renaissance Technologies
New York
|
+$158M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$725M |
| 2 |
GCGM
General Catalyst Group Management
Cambridge,
Massachusetts
|
-$251M |
| 3 |
Jennison Associates
New York
|
-$128M |
| 4 |
Morgan Stanley
New York
|
-$110M |
| 5 |
Amundi
Paris,
France
|
-$104M |
TDOC Hedge Fund Activity: Q4 2021 in Review
728 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q4 2021, worth a combined $13B — down 24% from $16.9B a quarter earlier.
Sellers outnumbered buyers: 142 funds closed out of TDOC and 124 opened new positions — a net loss of 18 holders — while 256 trimmed existing stakes and 233 added.
The largest buyer was ARK Investment Management, adding an estimated $294M. The largest seller was Capital World Investors, exiting entirely with an estimated $725M sold.
- 728 institutional investors held Teladoc Health (TDOC) as of Q4 2021, down from 760 in Q3 2021.
- Funds reported $13B of Teladoc Health stock for Q4 2021, down 24% quarter-over-quarter.
- 124 funds opened new Teladoc Health positions in Q4 2021 and 142 closed out, a net change of -18 holders.
- The largest Teladoc Health buyer in Q4 2021 was ARK Investment Management, an estimated $294M added.
- The largest Teladoc Health seller in Q4 2021 was Capital World Investors, an estimated $725M sold.
Based on aggregated 13F filings for Q4 2021.